FCGR2B

Chr 1AD

Fc gamma receptor IIb

Also known as: CD32, CD32B, FCG2, FCGR2, IGFR2

The protein encoded by this gene is a low affinity receptor for the Fc region of immunoglobulin gamma complexes. The encoded protein is involved in the phagocytosis of immune complexes and in the regulation of antibody production by B-cells. Variations in this gene may increase susceptibilty to systemic lupus erythematosus (SLE). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]

OMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 0.632 OMIM phenotypes
Clinical SummaryFCGR2B
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.20) despite low pLI — interpret in context.
📋
ClinVar Variants
26 VUS of 49 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.63LOEUF
pLI 0.456
Z-score 2.33
OE 0.20 (0.080.63)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.11Z-score
OE missense 0.97 (0.841.13)
131 obs / 134.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.20 (0.080.63)
00.351.4
Missense OE?0.97 (0.841.13)
00.61.4
Synonymous OE?1.17
01.21.6
LoF obs/exp: 2 / 9.9Missense obs/exp: 131 / 134.5Syn Z: -0.94

This gene — mechanism propensity

DN
0.77top 25%
GOF
0.73top 25%
LOF
0.2483th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

49 submitted variants in ClinVar

Classification Summary

VUS26
Likely Benign8
Benign3
Conflicting3
26
VUS
8
Likely Benign
3
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
0
0
0
Likely Pathogenic
0
0
0
0
0
VUS
0
25
1
0
26
Likely Benign
0
4
3
1
8
Benign
0
3
0
0
3
Conflicting
3
Total0324140

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

11 pathogenic / likely-pathogenic (of 22) ClinVar copy-number / structural variants overlap FCGR2B — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

FCGR2B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →